Diversify Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.19M Buy
97,290
+93,869
+2,744% +$7.57M 0.14% 159
2026
Q1
$271K Sell
3,421
-31,369
-90% -$3.01M 0.04% 175
2025
Q4
$3.37M Buy
34,790
+2,726
+9% +$265K 0.11% 144
2025
Q3
$2.89M Buy
32,064
+182
+0.6% +$16.7K 0.1% 159
2025
Q2
$2.94M Buy
31,882
+5,384
+20% +$457K 0.11% 134
2025
Q1
$2.24M Sell
26,498
-6,216
-19% -$556K 0.14% 112
2024
Q4
$2.64M Sell
32,714
-11,272
-26% -$976K 0.15% 106
2024
Q3
$4.01M Sell
43,986
-3,464
-7% -$291K 0.22% 86
2024
Q2
$3.65M Sell
47,450
-13,660
-22% -$1.12M 0.2% 93
2024
Q1
$5.32M Buy
+61,110
New +$5.22M 0.31% 66

Other funds holding MDT

Diversify Advisory Services's MDT Position: Q2 2026 in Review

Diversify Advisory Services increased its Medtronic (MDT) stake by 2,744% in Q2 2026, buying an estimated $7.57M and bringing the position to 97,290 shares worth $8.19M. The position accounts for 0.14% of the portfolio, ranked #159.

Diversify Advisory Services first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Diversify Advisory Services held 97,290 shares of Medtronic worth $8.19M as of Q2 2026.
  • Diversify Advisory Services bought 93,869 Medtronic shares in Q2 2026, an estimated $7.57M.
  • Medtronic made up 0.14% of Diversify Advisory Services's portfolio in Q2 2026, its #159 holding.
  • Diversify Advisory Services first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.